Interventions are actions taken by or for individuals to reduce the risk, duration, or severity of adverse health conditions. Interventions may be population-based or personal.
DCP2 and GBD present what we know about which health interventions work for a comprehensive range of diseases, injuries, and disabilities in many different contexts. A large share of the disease burden in low- and middle-income countries is attributable to diseases and conditions for which cost-effective interventions are already known and feasible. Selecting the right intervention for a given disease and context matters a great deal. The tools on this page are designed to aid the task.
DCP2 and GBD demonstrate how decision makers could use cost-effectiveness information in combination with information on disease prevalence and avertable illness to determine which interventions should be extended and which ones should be questioned. If developing countries scale up interventions and extend health care services that are cost-effective, the impact on the disease burden could be substantial.
Download Results (CSV)
|
Download Full Data Set (XLS)
| Condition |
Intervention
|
Intervention type
|
Intervention description |
Intervention setting
|
Objective
|
Target population
|
Cost effectiveness
(US$/DALY)
|
Cost effectiveness estimate
(US$)
|
Cost effectiveness range
(US$/DALY)
|
Number of DALYs averted
(hundreds)
|
Number of deaths averted
(hundreds)
|
Quality of cost-effectiveness analysis evidence
|
|
Lymphatic filariasis
|
Annual mass drug administration |
Population |
Two annual, single-dose, twodrug regimens are recommended: ivermectin plus albendazole in African countries that are coendemic for onchocerciasis, and diethylcarbamazine plus albendazole for all other endemic countries |
Clinic, Community
|
population-oriented medical intervention
|
All ages, Adults, Infants or children, Women of childbearing age, Pregnant women, Adolescents and adults, Mothers and infants
|
15 (South Asia) |
- |
4-27 (South Asia) |
-- |
-- |
4 (South Asia) |
|
Lymphatic filariasis
|
Diethyl carbamazine salt |
Population |
Fortification of salt with diethyl carbamazine |
Policy level
|
instrument of policy
|
All ages, Adults, Infants or children, Women of childbearing age, Pregnant women, Adolescents and adults, Mothers and infants
|
22 (South Asia) |
- |
1-43 (South Asia) |
-- |
-- |
4 (South Asia) |
|
Lymphatic filariasis
|
Vector control |
Population |
Integrated vector control to reduce overall prevalence of microfilaria parasites, such as polystyrene beads in vector (mosquito) breeding habitats |
Policy level
|
instrument of policy
|
All ages, Adults, Infants or children, Women of childbearing age, Pregnant women, Adolescents and adults, Mothers and infants
|
160 (South Asia) |
- |
43-277 (South Asia) |
-- |
-- |
4 (South Asia) |
Download Results (CSV)
|
Download Full Data Set (XLS)